| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11274-014-1712-2 |
| P698 | PubMed publication ID | 25108628 |
| P2093 | author name string | Nan Li | |
| Yan Jiang | |||
| Ping Zeng | |||
| Ting-ting Hu | |||
| Xiao-chun Huang | |||
| Yong-hong Tan | |||
| Shi-hua Wang | |||
| Rong-mei Liang | |||
| Yu-qin Duan | |||
| Hui-qing Shi | |||
| Xiao-lan Yong | |||
| Yun-ping Jiang | |||
| Zhao-hui Dong | |||
| Zi-ying Zhou | |||
| P2860 | cites work | Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus | Q43579575 |
| In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin | Q44608229 | ||
| The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee | Q45265404 | ||
| Berberine synergy with amphotericin B against disseminated candidiasis in mice | Q45296105 | ||
| Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study | Q46679472 | ||
| Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan | Q46782435 | ||
| Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. | Q54062872 | ||
| Antibiotics--an investment worth making? | Q79423613 | ||
| Counterpoint: Vancomycin and Staphylococcus aureus--an antibiotic enters obsolescence | Q80363323 | ||
| Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05 | Q80595494 | ||
| The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers | Q82846434 | ||
| Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains | Q83459256 | ||
| Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications | Q24646677 | ||
| Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus | Q28288905 | ||
| Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve | Q33181940 | ||
| Fusidic acid adverse drug reactions | Q33330342 | ||
| In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus | Q33556476 | ||
| Resistance to fusidic acid. | Q33755496 | ||
| Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation | Q33871653 | ||
| Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis | Q34309558 | ||
| Vancomycin: a 50-year reassessment | Q34472258 | ||
| Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus | Q34481625 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 | ||
| Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans | Q35781981 | ||
| Limitations of vancomycin in the management of resistant staphylococcal infections | Q36916076 | ||
| Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists | Q37537565 | ||
| In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains | Q39537168 | ||
| Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. | Q39544770 | ||
| A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. | Q39955761 | ||
| Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus | Q41269406 | ||
| Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. | Q41991408 | ||
| Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus | Q42001100 | ||
| Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin | Q42035117 | ||
| P433 | issue | 11 | |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| methicillin-resistant Staphylococcus aureus | Q595158 | ||
| P304 | page(s) | 2861-2869 | |
| P577 | publication date | 2014-08-10 | |
| P1433 | published in | World Journal of Microbiology and Biotechnology | Q15749216 |
| P1476 | title | Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). | |
| P478 | volume | 30 |
| Q36824291 | Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections |
| Q54935731 | Self-assembled filomicelles prepared from polylactide-poly(ethylene glycol) diblock copolymers for sustained delivery of cycloprotoberberine derivatives. |
| Q90096700 | The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile |
| Q40171649 | The effect of emodin on Staphylococcus aureus strains in planktonic form and biofilm formation in vitro |
Search more.